SOFINNOVA CAPITAL VI FCPR's Net Worth

$10.9 Million

Estimate Recalculated Sep 9, 2024 12:20AM EST

Who is SOFINNOVA CAPITAL VI FCPR

SOFINNOVA CAPITAL VI FCPR has an estimated net worth of $10.9 Million. This is based on reported shares across multiple companies, which include HOOKIPA Pharma Inc., BioAmber Inc., and Omthera Pharmaceuticals, Inc..

SEC CIK

SOFINNOVA CAPITAL VI FCPR's CIK is 0001441261

Past Insider Trading and Trends

2013 was SOFINNOVA CAPITAL VI FCPR's most active year for acquiring shares with 8 total transactions. SOFINNOVA CAPITAL VI FCPR's most active month to acquire stocks was the month of March. 2021 was SOFINNOVA CAPITAL VI FCPR's most active year for disposing of shares, totalling 8 transactions. SOFINNOVA CAPITAL VI FCPR's most active month to dispose stocks was the month of March. 2013 saw SOFINNOVA CAPITAL VI FCPR paying a total of $18,867,314.50 for 9,708,982 shares, this is the most they've acquired in one year. In 2021 SOFINNOVA CAPITAL VI FCPR cashed out on 728,620 shares for a total of $9,467,262.23, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

HOOKIPA Pharma Inc.

Investor
Updated Apr 23, 2021
Form 4
-9.37%
-328.62K
$11.60
-$3.81M
Apr 23, 2021
3.18M
Sale
Apr 21
Form 4
-1.04%
-36.83K
$13.67
-$503.57K
Mar 31, 2021
3.51M
Sale
ScheduledMar 29
Form 4
-0.98%
-35.17K
$13.69
-$481.64K
Mar 31, 2021
3.54M
Sale
ScheduledMar 26
Form 4
-0.79%
-28.55K
$13.12
-$374.57K
Mar 29, 2021
3.58M
Sale
ScheduledMar 25
Form 4
-1.44%
-52.69K
$13.70
-$721.62K
Mar 26, 2021
3.61M
Sale
ScheduledMar 24
Form 4
-1.08%
-40.00K
$13.91
-$556.48K
Mar 25, 2021
3.66M
Sale
ScheduledMar 23
Form 4
-1.08%
-40.53K
$14.54
-$589.26K
Mar 24, 2021
3.70M
Sale
ScheduledMar 22
Form 4
-4.26%
-166.23K
$14.60
-$2.43M
Mar 23, 2021
3.74M
Sale
ScheduledMar 19
Form 4
-0.01%
-300.00
$10.00
-$3.00K
Oct 06, 2020
3.91M
Sale
ScheduledOct 02
Form 4
-1.05%
-41.60K
$12.61
-$524.48K
Sep 17, 2020
3.91M
Sale
ScheduledSep 15
Form 4/A
-0.08%
-3.28K
$11.78
-$38.63K
Jul 24, 2020
3.96M
Sale
ScheduledJun 29
Form 4
-0.08%
-3.28K
$11.78
-$38.63K
Jul 22, 2020
3.96M
Sale
ScheduledJun 29
Form 4
-0.32%
-12.48K
$11.94
-$149.10K
Jul 22, 2020
3.95M
Sale
ScheduledJul 20
Form 4
-0.08%
-3.28K
$11.78
-$38.63K
Jul 01, 2020
3.96M
Sale
ScheduledJun 29
Form 4
9.90%
357.14K
$14.00
Apr 25, 2019
3.96M
Purchase
Apr 23
Form 3
Apr 17, 2019
82.46K
Showing 16 results

BioAmber Inc.

Investor
Updated May 16, 2013
Form 4
60.22%
1.76M
$10.00
$8.80M
May 16, 2013
4.68M
Purchase
May 14
Form 3
May 10, 2013
2.92M
Showing 2 results

Omthera Pharmaceuticals, Inc.

Investor
Updated Jul 18, 2013
Form 4
-100.00%
-7.16M
Jul 18, 2013
Disposition
Jul 18
Form 4
-18.70%
-1.65M
$7.56
$10.07M
Apr 18, 2013
7.16M
Sale
Apr 16
Form 4
789.47K
Apr 11, 2013
789.47K
Grant
Apr 11
Form 3
Apr 11, 2013
Showing 4 results